• Angiotensin 1/2 (5-7) in Cell Assays

  2026-08-21

  Learn how Angiotensin 1/2 (5-7), SKU A1049, can improve experimental control in cell viability, proliferation, cytotoxicity, and renin–angiotensin system studies. This scenario-based guide covers peptide identity, solubility, storage, assay interpretation, cross-domain SARS-CoV-2 research, and practical vendor-selection criteria.

• iPSC Platform for Ultrarare Disease Trials

  2026-08-20

  Sequiera et al. developed a patient-specific iPSC platform to prescreen therapies for an ultrarare ECHS1-associated Leigh-like syndrome before further clinical trial exposure. The study shows how matched healthy and disease controls, multisystem modeling, and metabolic profiling can support more informed treatment selection when genotype-specific evidence is scarce.

• Tioconazole Workflows for Antifungal Research

  2026-08-20

  Build more reproducible Tioconazole screens with solvent-aware preparation, orthogonal fungal readouts, and stress-state controls. This workflow connects ergosterol-focused antifungal assays with disciplined experimental design inspired by recent DNA-repair research, without overextending the evidence.

• Thiazovivin (A5506): Practical ROCK Inhibition

  2026-08-19

  Thiazovivin is a ROCK inhibitor for research workflows involving fibroblast reprogramming, induced pluripotent stem cell generation, and human embryonic stem cell survival after dissociation. This guide covers handling, stock preparation, controls, and troubleshooting; the compound is not intended for diagnostic, therapeutic, or clinical use.

• SIX1 Control of Lipogenesis in Liver Cancer

  2026-08-19

  The reference study identifies SIX1 as a direct transcriptional regulator of de novo lipogenesis in liver cancer cells, linking ACLY, FASN, and SCD1 expression to a DGUOK-AS1–miR-145-5p regulatory axis. Its findings connect lipid metabolic control with tumor proliferation, invasion, and metastasis, while highlighting DGUOK-AS1 as a potential prognostic indicator and therapeutic entry point.

• Pemetrexed: Linking Folate Stress to DNA Repair

  2026-08-18

  Pemetrexed is more than a broad cytotoxic control: it can serve as a mechanistic probe connecting folate-dependent nucleotide depletion with DNA-repair phenotypes. This guide shows how to build better tumor-cell assays around pemetrexed disodium and interpret results in malignant mesothelioma research.

• ACE Inhibitors and Cell-Surface Aminopeptidases

  2026-08-18

  Tieku and Hooper directly compared inhibitor profiles across porcine kidney aminopeptidases N, A, and W, revealing substantial differences between bestatin, related aminopeptidase inhibitors, and angiotensin converting enzyme inhibitors. The study provides a useful framework for distinguishing intended ACE inhibition from possible off-target effects on cell-surface zinc aminopeptidases.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-08-17

  The reference study establishes an accessible direct 3D culture strategy for generating expandable, cryopreservable intestinal organoids from human induced pluripotent stem cells. Its organoid-derived intestinal epithelial cells contain mature enterocyte-like populations with cytochrome P450 and transporter activities, providing a human-relevant platform for absorption and metabolism studies.

• Nadolol (SQ-11725): A Translational Lens

  2026-08-17

  Nadolol (SQ-11725) offers translational researchers a defined way to interrogate non-selective beta-adrenergic blockade while accounting for transporter biology, disease-state pharmacokinetics, and assay design. This article connects cardiovascular mechanism with lessons from recent MASH pharmacokinetic research.

• Hematoxylin and Eosin Staining Kit Guide

  2026-08-16

  The Hematoxylin and Eosin Staining Kit provides ready-to-use hematoxylin and eosin solutions for visualizing nuclei, cytoplasm, and extracellular tissue features in research samples. It supports histopathological and cytological workflows involving paraffin-embedded or frozen sections, but it is intended for scientific research only and not for diagnostic or medical use.

• KU-55933: ATM Kinase Inhibitor Workflow Guide

  2026-08-15

  Use KU-55933 to dissect ATM-dependent signaling, cell-cycle control, and metabolic stress in cancer and patient-derived cellular models. This practical guide combines selective pathway interrogation with iPSC-inspired controls, assay design, and troubleshooting for more reproducible cancer research.

• Angiotensin 1/2 (1-6): An Assay Design Guide

  2026-08-14

  Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, is more than a RAS reagent: its sequence context makes it a useful probe for fragment-specific biology. This guide translates cardiovascular, renal, and emerging spike–receptor binding evidence into practical assay design and interpretation decisions.

• (-)-Blebbistatin for Cardiac Mechanobiology

  2026-08-14

  Use (-)-Blebbistatin as a reversible actomyosin perturbation layer alongside transparent microelectrode arrays to separate electrical, metabolic, and mechanical effects in cardiac models. This workflow connects selective non-muscle myosin II inhibition with cytoskeletal, contractility, and multimodal bioelectronic assays.

• MnTBAP Chloride: Reading Redox Rescue

  2026-08-13

  MnTBAP Chloride is more than a superoxide-scavenging reagent: it can help researchers distinguish mitochondrial redox involvement from downstream inflammatory and behavioral consequences. This article presents a compartment-aware framework for interpreting rescue experiments in oxidative stress and chronic-stress models.

• Antiarrhythmic Drugs and Cardiac SK Channels

  2026-08-13

  The reference study systematically tested clinically used antiarrhythmic drugs against human KCa2.2 and KCa2.3 channels using automated whole-cell patch clamp. Dofetilide and propafenone inhibited these channels only at concentrations far above effective free therapeutic exposure, while Dronedarone did not emerge as a meaningful KCa2.X blocker, refining how its antiarrhythmic pharmacology should be interpreted.

552 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page